Global Plasma Fractionation Market Size, Share, Forecast Report, 2020-2027

The global Plasma Fractionation market garnered revenue around USD XX Billion in 2019 and projected to reach USD XX Billion in 2027, with at a compound annual growth rate of XX% throughout the estimate period from 2020 to 2027.

Rising participation of market players is one of the key factors driving the plasma fractionation market. For instance, in 2018, Grifols acquired 24 plasma donation centers in the United States operated by Biotest Pharmaceuticals Corp. for USD 286 million. With this acquisition, Grifols now owns 249 plasma donation centres to increase its supply of plasma proteins used for therapeutic purposes.

Various other factors such as increasing geriatric population, technological advancements, emerging markets in APAC and RoW, rising plasma collection, and increasing prevalence of respiratory and autoimmune disorders are also expected to propel the growth of the market.

However, the emergence of recombinant alternatives, high cost of advanced products, and unfavourable reimbursement policies can hamper the market growth over the forecast period.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Plasma Fractionation market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Plasma Fractionation market growth.

The global Plasma Fractionation market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

• Bio Products Laboratory (BPL)

• Biotest AG

• China Biologic Products Holdings, Inc.

• CSL Limited

• Green Cross Corporation

• Grifols, S.A.

• Japan Blood Products Organization

• Kedrion S.p.A

• LFB group

• Octapharma AG

• Sanquin

• Shanghai RAAS

• Shire

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Market Segmentation and Key Market Players

Global Plasma Fractionation Market, by Product

• Immunoglobulin

o Intravenous Immunoglobulin (IVIG)

o Subcutaneous Immunoglobulin (SCIG)

o Others

• Coagulation Factor Concentrates

o Factor VIII

o Factor IX

o Von Willebrand Factor

o Prothrombin Complex Concentrate

o Fibrinogen Concentrates

o Factor XIII

• Albumin

• Protease Inhibitors

• Others

Global Plasma Fractionation Market, by Application

• Immunology

• Neurology

• Hematology

• Critical Care

• Pulmonology

• Rheumatology

• Hemato-Oncology

• Others

Global Plasma Fractionation Market, by End User

• Hospitals & Clinics

• Clinical Research Laboratories

• Academic Institutes

• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America

 U.S.

 Canada

• Europe

 Germany

 U.K.

 Italy

 France

 Rest of EU

• Asia Pacific

 China

 India

 Japan

 Southeast Asia

 Rest of APAC

• Central & South America

 Brazil

 Argentina

 Rest of Central & South America

• Middle East and Africa

 UAE

 Saudi Arabia

 Rest of MEA